Vancouver, Canada, April 19, 2007 /PRNewswire/--MicroDTI announced the appointment of Edward Shellard as its Chief Executive Officer. Dr. Shellard is a well-respected dental industry executive and was most recently the President of Kerr.
Ed had his own private practice in Rochester, NY from 1987 to 1994. During this time, Ed also consulted for the Dental Products group of Eastman Kodak. In 1994, Ed sold his practice to join Kerr, one of the oldest and most well-respected dental products company in the world. Since then, he has held positions of increasing responsibility in clinical affairs, business development, R&D, marketing, and was instrumental in the acquisition and integration of numerous companies. Most recently, he served as President of Kerr, which during his 13 years there grew from a $120 million to a $300 million division of Sybron Dental Specialties and Danaher Corp. Ed has a BA from Ohio Wesleyan University, a DMD from Case Western Reserve University Dental School and an MBA from Pepperdine University.
John H. Foster, Chairman of the Board of MicroDTI and Chairman of HealthpointCapital LLC, said, "After an extensive search process, we are excited to bring an executive as talented as Ed on board to lead MicroDTI. He possesses a rare combination of both clinical and executive experience. His focus on and understanding of the needs of dentists, and accomplishments in functions as diverse as R&D and marketing will keep MicroDTI at the forefront of the industry."
MicroDTI
MicroDTI is the world's largest and most advanced cosmetic dental laboratory. It custom designs and fabricates crowns, bridges, dentures, cosmetic appliances and orthodontic appliances for its customers, dentists serving patients in need of restorative and cosmetic dentistry. MicroDTI was founded in 1997 and has grown into one of the largest dental laboratory companies in the world with 900 employees across 19 locations in Canada and the United States. MicroDTI is a portfolio company of HealthpointCapital.
HealthpointCapital, LLC
HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on orthopedic and the broadly based musculoskeletal businesses, the fastest growing segment within the medical device industry. Our cumulative 70 years of experience in healthcare technology, research and private investing enable us to help our clients capitalize on the explosive growth and unique investment opportunities in this sector. HealthpointCapital has approximately $600 million of institutional capital under management.
